CA

Ronald Reagan Presidential Foundation and Institute Announces Retirement of Executive Director

Retrieved on: 
Mercoledì, Agosto 4, 2021
Quayle Vice Presidential Learning Center, Public affairs, Ronald Reagan, Atmosphere of Earth, Board of directors, Trustee, Foundation, CA, Board, Hawaii Children's Discovery Center, Hwa Chong Institution Boarding School, Director, Institute, Presidential Museum, George H.W. Bush Presidential Library and Museum, Simi, Management

SIMI VALLEY, Calif., Aug. 4, 2021 /PRNewswire/ --The Ronald Reagan Presidential Foundation and Institute Board of Trustees has announced that after twelve years of service leading the Foundation, its Executive Director, John D. Heubusch, will retire on December 31, 2021.

Key Points: 
  • SIMI VALLEY, Calif., Aug. 4, 2021 /PRNewswire/ --The Ronald Reagan Presidential Foundation and Institute Board of Trustees has announced that after twelve years of service leading the Foundation, its Executive Director, John D. Heubusch, will retire on December 31, 2021.
  • "It's been the honor of my life to preserve and promote the legacy of Ronald Reagan with so many talented people at such a special place," said Heubusch.
  • The Ronald Reagan Presidential Foundation and Institute is the nonprofit organization created by President Reagan himself and specifically charged by him with continuing his legacy and sharing his principles - individual liberty, economic opportunity, global democracy and national pride.
  • The Foundation is a non-partisan organization which sustains the Ronald Reagan Presidential Library and Museum in Simi Valley, CA, the Reagan Center for Public Affairs, the Presidential Learning Center, The Air Force One Pavilion and the award-winning Discovery Center, as well as the Reagan Institute, which carries out the Foundation's work in Washington, D.C.

FCPT Announces Second Quarter 2021 Financial and Operating Results

Retrieved on: 
Mercoledì, Agosto 4, 2021
REIT, Restaurant, Bar, Retail, Commercial Building & Real Estate, Construction & Property, GAAP, Generally Accepted Accounting Principles, New York Stock Exchange

Four Corners Property Trust, Inc. (FCPT or the Company) (NYSE: FCPT) today announced financial results for the three months and six months ended June 30, 2021.

Key Points: 
  • Four Corners Property Trust, Inc. (FCPT or the Company) (NYSE: FCPT) today announced financial results for the three months and six months ended June 30, 2021.
  • AFFO per diluted share for the second quarter was $0.38, representing a $0.04 per share increase compared to the same quarter in 2020.
  • FCPT declared a dividend of $0.3175 per common share for the second quarter of 2021.
  • Notice Regarding Non-GAAP Financial Measures:
    In addition to U.S. GAAP financial measures, this press release and the referenced supplemental financial and operating report contain and may refer to certain non-GAAP financial measures.

Odyssey Group International Completes IND-enabling Studies, Submits Investigator’s Brochure for Phase 1 Clinical Trial

Retrieved on: 
Mercoledì, Agosto 4, 2021
Health sciences, Life sciences, Natural sciences, Pharmaceutical industry, Drug discovery, Clinical research, Food and Drug Administration, Clinical pharmacology, Clinical trial, Pharmacology, Drug development, ADME

Having successfully completed our IND-enabling studies and Investigational Brochure we have taken a large step closer to launching human clinical trials for a potential treatment for this unmet medical need, commented Jacob VanLandingham, Executive VP of Drug Development of Odyssey Group International.

Key Points: 
  • Having successfully completed our IND-enabling studies and Investigational Brochure we have taken a large step closer to launching human clinical trials for a potential treatment for this unmet medical need, commented Jacob VanLandingham, Executive VP of Drug Development of Odyssey Group International.
  • The IB includes the pre-clinical safety and efficacy data, the design for Phase 1 clinical trials and the informed consent to enroll subjects in the trial.
  • These study areas include the following: Safety Pharmacology, Toxicology, CMC (Chemistry Manufacturing and Control) activities, ADME (Absorption, Distribution, Metabolism and Excretion) and Genotoxicity.
  • said Michael Redmond, CEO of Odyssey Group International
    Odyssey Group International, Inc. (OTC: ODYY ) is a technology and asset acquisition company with a focus in the area of life saving medical solutions.

Green Stream Holdings, Inc., Receives First Of Five Topographical Surveys: Survey For 607 Station Road, Bellport, NY, Has Been Completed & Delivered

Retrieved on: 
Mercoledì, Agosto 4, 2021
Madeline, Surveying, SOLAR, Video games, Video gaming, Creative works

The Company had previously contracted with a land surveyor, Ramsay Land Surveying, PC to conduct Topographical Surveys and/or Elevation Certificates for five sites in New York.

Key Points: 
  • The Company had previously contracted with a land surveyor, Ramsay Land Surveying, PC to conduct Topographical Surveys and/or Elevation Certificates for five sites in New York.
  • Its an exciting time for the Company, and we are looking forward to taking the next steps with these properties and others to follow.
  • The Company is currently targeting high-growth solar market segments for its advanced solar greenhouse and advanced solar battery products.
  • Chuck's Vintage was founded by GSFI former CEO Madeline Cammarata (fka Madeline Harmon), who hailed from an illustrious background in fashion.

MadCap Software Bridges the Digital Divide Between Instructional Designers and Technical Communicators with New MadCap Flare 2021 r2 Release for eLearning

Retrieved on: 
Mercoledì, Agosto 4, 2021
Articles, Technical communication tools, Education, MadCap Software, Madcap, Technical communication, Instructional design

With the latest MadCap Flare release, technical authors can add greater value to the content they create by incorporating interactive, eLearning features.

Key Points: 
  • With the latest MadCap Flare release, technical authors can add greater value to the content they create by incorporating interactive, eLearning features.
  • The roles of technical communicators and instructional designers in educating customers, partners, employees, and others have long been intertwined.
  • With our 2021 r2 release of MadCap Flare, technical authors and instructional designers have state-of-the art capabilities for delivering all documentation and eLearning content from a single product.
  • MadCap Software, the MadCap Software logo, MadCap Authoring and Management System, MadCap Central, MadCap Flare, MadCap Mimic, MadCap Capture, MadCap Lingo, and MadCap Connect are trademarks or registered trademarks of MadCap Software, Inc. in the United States and/or other countries.

Global WholeHealth Partners Corp (OTC: GWHP) Has Been Approved to Sell Its Products Through Walmart Online as Stated in the 8K Filing 08/03/2021

Retrieved on: 
Mercoledì, Agosto 4, 2021
Retailers, Retailing, Clinical Laboratory Improvement Amendments, Healthcare in the United States, Walmart, Food and Drug Administration, EMC2, Regulation

San Clemente, CA, Aug. 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global is planning on selling the Pregnancy, Ovulation, Drug Tests, Glucose, and Colorectal Cancer Tests to start the retail marketing.

Key Points: 
  • Walmart Inc.s online sales grew 79% for its fiscal year 2021, which ended Jan. 29.
  • Global WholeHealth Partners Corp (OTC: GWHP)through the EMC2 agreement is funded for growth, sales, and expansion.
  • Currently, the Company has 70 products FDA approved and many are approved for OTCuse, and 29 POC products approved by the FDA CLIA WAIVED.
  • Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov .

VeeMed Unveiling VeeGo 360, New All-in-One Remote Patient Monitoring Platform at HIMSS21

Retrieved on: 
Mercoledì, Agosto 4, 2021
Articles, Health informatics, Technology, Telemedicine, Science and technology, Telehealth, Assistive technology, Remote patient monitoring, EHealth

ROSEVILLE, Calif. and LAS VEGAS, Aug. 04, 2021 (GLOBE NEWSWIRE) -- VeeMed, provider of a complete telehealth platform for the full continuum of healthcare, today announced VeeGo 360, an all-in-one remote patient monitoring platform (RPM).

Key Points: 
  • ROSEVILLE, Calif. and LAS VEGAS, Aug. 04, 2021 (GLOBE NEWSWIRE) -- VeeMed, provider of a complete telehealth platform for the full continuum of healthcare, today announced VeeGo 360, an all-in-one remote patient monitoring platform (RPM).
  • VeeGo 360 enables device management, teleconsults and monitoring services, representing one of the few fully integrated RPM platforms available today.
  • VeeMed will demo VeeGo 360 at HIMSS21 , held Aug. 9-13, in booth 7621 located in the Venetian-Sands Expo Center.
  • Founded in 2016, VeeMed has the most advanced telemedicine solutions for the entire continuum of care from acute care settings to outpatient and remote patient monitoring.

Fate Therapeutics Appoints Yuan Xu to its Board of Directors

Retrieved on: 
Mercoledì, Agosto 4, 2021
United Therapeutics, Trubion

SAN DIEGO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer, today announced the appointment of Yuan Xu, Ph.D., to its Board of Directors as an independent director.

Key Points: 
  • SAN DIEGO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer, today announced the appointment of Yuan Xu, Ph.D., to its Board of Directors as an independent director.
  • Dr. Xu currently serves as an independent director on the board of directors of Akero Therapeutics, Inc. (Nasdaq: AKRO).
  • Fate Therapeutics iPSC product platform is supported by an intellectual property portfolio of over 350 issued patents and 150 pending patent applications.
  • Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for patients with cancer.

Creo successfully completes commercial fermentation run

Retrieved on: 
Mercoledì, Agosto 4, 2021
Branches of biology, Academic disciplines, Articles, Roy Lipski, Entheogens, Euphoriants, Metabolism, Cannabinoid, Cannabis, PTC Creo, Creo, Fermentation

San Diego, CA August 4, 2021 Creo , an ingredient technology company with a proprietary platform for producing natural cannabinoids without the cannabis plant, announced today the successful completion of its first commercial fermentation run at 28,000 L scale with performance that exceeded the Companys expectations.

Key Points: 
  • San Diego, CA August 4, 2021 Creo , an ingredient technology company with a proprietary platform for producing natural cannabinoids without the cannabis plant, announced today the successful completion of its first commercial fermentation run at 28,000 L scale with performance that exceeded the Companys expectations.
  • The commercial fermentation produced CBGA which is being processed into finished CBGA and CBG for client sampling and sales.
  • Were pleased with the performance of this commercial fermentation run at 28,000 L, which follows our successful demonstration campaign in January said Creos CEO, Roy Lipski.
  • Creo is an ingredients technology company that produces high quality cannabinoids using the natural process of fermentation.

UserTesting Study Explores America’s Most Popular Outdoor Activities and Associated Travel Plans

Retrieved on: 
Mercoledì, Agosto 4, 2021
Women, Software, Sports, Men, Data Management, Technology, Outdoors, Consumer

At least 60 percent of men and 50 percent of women stated that they take part in these activities on a weekly basis.

Key Points: 
  • At least 60 percent of men and 50 percent of women stated that they take part in these activities on a weekly basis.
  • Watch this video to hear respondents share their thoughts on the activities they plan to participate in this summer.
  • Watch this video to hear respondents share their thoughts on their level of participation in summer outdoor activities.
  • Watch this video to hear respondents share their thoughts on purchases they plan to make for their summer outdoor activities.